HCCI research Kevin Kennedy was quoted in a Crain's New York Business story on hospital price transparency rules. From the article: "It was pretty clear that the $300 a day wasn't going to be that much of an incentive for hospitals to comply when you're talking about multi-million- or -billion-dollar businesses," said Kevin Kennedy, a researcher at the Health Care Cost Institute, ...
HCCI's research on insulin prices was featured in a USA Today article on COVID-19 vaccine misinformation. From the article: "Insulin prices nearly doubled in the U.S from 2012 to 2016, a 2019 report by the nonprofit Health Care Cost Institute found." Fact check: False claim links COVID-19 vaccine's price, effectiveness Even though almost all COVID-19 deaths are occurring among unvaccinated p...
HCCI's created a list of most common outpatient procedures used in an article on the difficulty of using hospital price transparency data. Effort to Decipher Hospital Prices Yields Key Finding: Don’t Try It at Home - News Nation USA A federal price transparency rule that took effect this year was supposed to give patients, employers and insurers a clearer picture of the true cost of https://...
Introduction This study assesses the associations between the recent implementation of robust features of state Prescription Drug Monitoring Programs and the abrupt discontinuation of long-term opioid therapies. Methods Data were from a national commercial insurance database and included privately insured adults aged 18–64 years and Medicare Advantage enrollees aged ≥65 years who initiated a...
HCCI's research on insulin prices was featured in USA Today. From the article: "The lower-cost insulin is being released by Walmart in response to surging costs for the treatment used for patients with diabetes. According to the Health Care Cost Institute, a non-profit organization which sheds light on health care spending, the average price for an insulin prescription nearly doubled from 2012 ($3...
